-+ 0.00%
-+ 0.00%
-+ 0.00%

Halozyme director Dannielle Appelhans files initial beneficial ownership statement

PUBT·08/21/2026 20:56:01
Listen to the news
Halozyme director Dannielle Appelhans files initial beneficial ownership statement
  • Halozyme filed a Form 3 naming Dannielle Appelhans as a director in an initial statement of beneficial ownership dated Aug. 14, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Halozyme Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001159036-26-000115), on August 21, 2026, and is solely responsible for the information contained therein.